COVID-19 and Diabetes Mellitus:  Are there any Differences in Outcomes with Anti-Diabetic Drugs?

dc.contributor.author	Alibeyoğlu, Alpay
dc.contributor.author	ŞENKAL, Naci
dc.contributor.author	SARIBEYLİLER, GÖKTUĞ
dc.contributor.author	ÇATMA, YUNUS
dc.contributor.author	KÖSE, MURAT
dc.contributor.author	ÇAKMAK, RAMAZAN
dc.contributor.author	TELCİ ÇAKLILI, ÖZGE
dc.contributor.author	ÇELİK, AYŞE MERVE
dc.contributor.author	MUTLU, ÜMMÜ
dc.contributor.author	Nasıfova, Vefa
dc.date.accessioned	2022-07-04T12:20:26Z
dc.date.available	2022-07-04T12:20:26Z
dc.date.issued	2021
dc.identifier.citation	ÇAKMAK R., TELCİ ÇAKLILI Ö., ÇELİK A. M. , MUTLU Ü., Nasıfova V., SARIBEYLİLER G., Alibeyoğlu A., ÇATMA Y., ŞENKAL N., KÖSE M., "COVID-19 and Diabetes Mellitus: Are there any Differences in Outcomes with Anti-Diabetic Drugs?", Turkish Journal of Diabetes and Obesity, cilt.5, sa.3, ss.279-284, 2021
dc.identifier.issn	2587-0335
dc.identifier.other	vv_1032021
dc.identifier.other	av_176ba888-a7b6-4653-a322-8203fae80e7d
dc.identifier.uri	http://hdl.handle.net/20.500.12627/181753
dc.identifier.uri	https://doi.org/10.25048/tudod.959022
dc.language.iso	tur
dc.title	COVID-19 and Diabetes Mellitus: Are there any Differences in Outcomes with Anti-Diabetic Drugs?
dc.type	Makale
dc.relation.journal	Turkish Journal of Diabetes and Obesity
dc.contributor.department	, ,
dc.identifier.volume	5
dc.identifier.issue	3
dc.identifier.startpage	279
dc.identifier.endpage	284
dc.contributor.firstauthorID	3402597

Files in this item

Files	Size	Format	View
There are no files associated with this item.